Inflammatory Cytokines Interleukin-6 and Oncostatin M Induce Plasminogen Activator Inhibitor-1 in Human Adipose Tissue

Johann Wojta(Medical University of Vienna), Manfred Frey(Radboud University Nijmegen), Daniela Seidinger(Wilhelminen Hospital), Stefan Kastl(Medical University of Vienna), Sabine Steiner(Helmholtz Munich), T Weiss(Ludwig Boltzmann Institute for Cardiovascular Research), Christoph Kopp(Friedrich-Alexander-Universität Erlangen-Nürnberg), Gerald Maurer(European Society of Radiology), Svitlana Demyanets(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna), Gerlinde Zorn(Wilhelminen Hospital), Robert Roehle(Humboldt-Universität zu Berlin)
Circulation
April 18, 2005
10.1161/01.cir.0000161823.55935.be
Cited by 93

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755